Showing 20 of 21 recruiting trials for “Squamous cell carcinoma of the oropharynx”
ctHPVDNA in HPV Positive Squamous Cell Carcinoma of the Oropharynx
👨⚕️ Michael Sim, MD, Indiana University Melvin and Bren Simon Comprehensive Cancer Center📍 2 sites📅 Started Jun 2025View details ↗
Intratumoral Lidocaine Injection Before Oropharyngeal Cancer Surgery
The Minimalist Trial-2
👨⚕️ Douglas Adkins, M.D., Washington University School of Medicine📍 1 site📅 Started Apr 2025View details ↗
Phase 1 Clinical Trial of FluBHPVE6E7 Immunotherapy for HPV16-Associated Oropharyngeal Cancer
Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer
SURVEILLE-HPV: Evaluation of HPV16 Circulating DNA as Biomarker to Detect the Recurrence, in Order to Improve Post Therapeutic Surveillance of HPV16-driven Oropharyngeal Cancers
Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal Cancer
👨⚕️ Sujith Baliga, Ohio State University Comprehensive Cancer Center📍 1 site📅 Started Mar 2024View details ↗
Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)
👨⚕️ Jason K Molitoris, MD, PhD, University of Maryland/Maryland Proton Treatment Center📍 5 sites📅 Started Mar 2024View details ↗
Identification of Individual Histological and Blood Markers in Patients With Recurrent or Metastatic Upper Aerodigestive Tract Squamous Cell Carcinoma in Response to Immunotherapies
RecruitingNCT05862792 ↗
Liposomal Bupivacaine and Transoral Robotic Surgery
RecruitingNCT05649865 ↗
Monitoring and Early Response Evaluation Using HPV DNA - A Study on Patients With HPV-positive Throat Cancer (MER-HPV)
👨⚕️ Johanna Sjövall, MD,PhD, Dept. of clincial sciences, Lund University📍 1 site📅 Started May 2023View details ↗
RecruitingNCT05522881 ↗
The Registry Study of Genetic Alterations of Oropharyngeal Cancer in Taiwan
👨⚕️ Pei-Jen Lou, MD, PhD, National Taiwan University Hospital📍 7 sites📅 Started Nov 2022View details ↗
RecruitingNCT05600842 ↗
De-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx
Training Swallowing Initiation During Expiration
👨⚕️ Bonnie Martin-Harris, PhD, Northwestern Memorial Hospital📍 2 sites📅 Started May 2022View details ↗
RecruitingNCT05918510 ↗
Observational Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult Tumors Positive for Papilloma Virus
Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study
👨⚕️ Jonathan D Schoenfeld, MD, MPH, Dana-Farber Cancer Institute📍 2 sites📅 Started Jul 2021View details ↗
p16+ Oropharyngeal Cancer Radiation Optimization Trial Reducing Elective Treatment Volumes (PROTEcT)
RecruitingNCT04564989 ↗
Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC
Testing Less Intensive Radiation With Chemotherapy to Treat Low-risk Patients With HPV-positive Oropharyngeal Cancer
👨⚕️ Gregory Biedermann, MD, University of Missouri - Ellis Fischel Cancer Center📍 1 site📅 Started Sep 2020View details ↗
Radiotherapy vs. Trans-Oral Surgery for HPV-Negative Oropharyngeal Squamous Cell Carcinoma
👨⚕️ Danielle MacNeil, M.D., London Regional Cancer Program, London Health Sciences Centre📍 1 site📅 Started Jun 2020View details ↗
Page 1 of 2Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →